Tag: Femara
Articles
- How important is Vitamin D before and after breast cancer diagnosis?
- Latest research concerning impact of endocrine therapy on breast cancer prognosis
- What should breast cancer survivors eat during aromatase inhibitor treatment?
News
- A story of long-term stage IV HER2+ breast cancer survival
- Aromatase inhibitor only or after tamoxifen are both effective treatments
- Aromatase inhibitors can increase risk of early hip fracture in breast cancer survivors
- Aromatase inhibitors can worsen cholesterol profile
- Aromatase inhibitors can worsen sexual function after breast cancer
- Aromatase inhibitors have numerous side effects in addition to musculoskeletal symptoms
- Bisphosphonate Zometa might increase survival in certain premenopausal breast cancer cases
- Cognitive function improves after completion of both Femara and tamoxifen treatment
- Increasingly severe side effects of aromatase inhibitors may make tamoxifen first the best strategy
- Strongly estrogen positive lobular breast cancer responds well to neoadjuvant Femara
- Switch in aromatase inhibitors can enable some with breast cancer to continue AI treatment
- Tamoxifen treatment results in cognitive impairment compared to Aromasin
- Treatment with aromatase inhibitors results in better breast cancer outcomes than tamoxifen
- Vitamin D levels often low even in breast cancer survivors taking supplements
- Weight gain can increase hot flashes in breast cancer survivors on aromatase inhibitors
Foods
Studies
- A Pilot Study of Letrozole for One Year in Women at Enhanced Risk of Developing Breast Cancer: Effects on Mammographic Density
- Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer
- Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07)
- Changes in cognitive function in postmenopausal women 1 year after completing adjuvant letrozole or tamoxifen in the Breast International Group (BIG) 1-98 trial
- Comparison of Changes in the Lipid Profile of Postmenopausal Women With Early Stage Breast Cancer Treated With Exemestane or Letrozole
- Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo
- Early operable breast cancer in elderly women treated with an aromatase inhibitor letrozole as sole therapy
- Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study
- Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer
- Evaluating Letrozole and Tamoxifen Alone and in Sequence at 8 Years Median Follow-up for Postmenopausal Women With Steroid Hormone Receptor-Positive Breast Cancer
- Final 5-year results of Z-FAST trial: Adjuvant Zoledronic Acid Maintains Bone Mass in Postmenopausal Breast Cancer Patients Receiving Letrozole
- Invasive lobular carcinoma: response to neoadjuvant letrozole therapy
- Longer-Term Outcomes of Letrozole Versus Placebo After 5 Years of Tamoxifen in the NCIC CTG MA.17 Trial: Analyses Adjusting for Treatment Crossover
- Sexual Function after Breast Cancer
- Side effects associated with aromatase inhibitor treatment among breast cancer patients
- Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer
- Surgery for widely disseminated breast cancer: prolonged control by excision of metastases
- The Protective Effect of Zoledronic Acid on Bone Loss in Postmenopausal Women with Early Breast Cancer Treated with Sequential Tamoxifen and Letrozole: A Prospective, Randomized, Phase II Trial
- Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis
- Vitamin D Deficiency in Post-Menopausal Breast Cancer Survivors